UBP 301 - ≥98%(HPLC) , CAS No.569371-10-4

CAS: 569371-10-4 Cat. No.: U288472 分子式: C15H14IN3O6 分子量: 459.20 PubChem CID: 6604913
注文可能
GRADE & PURITY ≥98%(HPLC)
Synonyms
(αS)-α-Amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinepropanoic acid
Storage
Store at 2-8°C,Protected from light
Shipped In
Wet ice
★
Size
USA
ドイツ (EU)*
Price
Qty
1mg
U288472-1mg
受注生産 · 8~12週間
$99.90
5mg
U288472-5mg
受注生産 · 8~12週間
$319.90
10mg
U288472-10mg
受注生産 · 8~12週間
$559.90
25mg
U288472-25mg
受注生産 · 8~12週間
$979.90
50mg
U288472-50mg
受注生産 · 8~12週間
$1,379.90
Enter a quantity for the sizes you want to add.
🧪
Why this grade

≥98%(HPLC) for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at 2-8°C,Protected from light Ships Wet ice Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

概要

UBP301 is a potent and selective kainate receptor antagonist with IC50 and KD values of 164 μM and 5.94 μM, respectively. UBP301 is 30 times more selective to chloric acid receptors than AMPA receptors. UBP301 is a derivative of Willardiine

Specifications

同義語
(αS)-α-Amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-5-iodo-2,4-dioxo-1(2H)-pyrimidinepropanoic acid
仕様と純度
≥98%(HPLC)
生化学的・生理学的メカニズム
Potent kainate receptor antagonist (apparent Kd= 5.94μM). Displays ~ 30-fold selectivity over AMPA receptors.
保管条件
Store at 2-8°C,Protected from light
入荷
Wet ice
この製品は冷冷この冷このこの製品の運送が必要です。地上およびその他の経済サービスは利用できません。
純度
≥98%(HPLC)
名前と識別子
カノニカル・スマイル
C1=CC(=CC=C1CN2C(=O)C(=CN(C2=O)CC(C(=O)O)N)I)C(=O)O
IUPAC Name
4-[[3-[(2S)-2-amino-2-carboxyethyl]-5-iodo-2,6-dioxopyrimidin-1-yl]methyl]benzoic acid
InChIKey
JHSYCOCOIYSZGI-NSHDSACASA-N
INCHI
1S/C15H14IN3O6/c16-10-6-18(7-11(17)14(23)24)15(25)19(12(10)20)5-8-1-3-9(4-2-8)13(21)22/h1-4,6,11H,5,7,17H2,(H,21,22)(H,23,24)/t11-/m0/s1
異性体SMILES
C1=CC(=CC=C1CN2C(=O)C(=CN(C2=O)C[C@@H](C(=O)O)N)I)C(=O)O
PubChem CID
6604913
分子量
459.20

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
分類Carboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Amino acids and derivatives - Alpha amino acids and derivatives - Alpha amino acids
Direct ParentL-alpha-amino acids
Alternative Parents Benzoic acids  Benzoyl derivatives  Pyrimidones  Halopyrimidines  Aryl iodides  Hydropyrimidines  Dicarboxylic acids and derivatives  Vinylogous amides  Heteroaromatic compounds  Ureas  Amino acids  Lactams  Azacyclic compounds  Carboxylic acids  Carbonyl compounds  Hydrocarbon derivatives  Monoalkylamines  Organic oxides  Organoiodides  Organopnictogen compounds  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents L-alpha-amino acid - Benzoic acid - Benzoic acid or derivatives - Benzoyl - Pyrimidone - Halopyrimidine - Aryl iodide - Aryl halide - Monocyclic benzene moiety - Hydropyrimidine - Benzenoid - Pyrimidine - Dicarboxylic acid or derivatives - Heteroaromatic compound - Vinylogous amide - Amino acid - Urea - Lactam - Carboxylic acid - Organoheterocyclic compound - Azacycle - Amine - Primary aliphatic amine - Organohalogen compound - Organoiodide - Organonitrogen compound - Organooxygen compound - Carbonyl group - Primary amine - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Organic oxygen compound - Organic nitrogen compound - Aromatic heteromonocyclic compound
説明This compound belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom.
External Descriptors Not available
3 D構造
インタラクティブ化学構造モデル





関連ターゲット(人間)
VDR Tclin Vitamin D receptor (26531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TSHR Tclin Thyroid stimulating hormone receptor (29986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIK1 Tclin Glutamate receptor ionotropic kainate 1 (340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
関連ターゲット(非人間)
Grik2 Glutamate receptor ionotropic kainate 2 (298 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
lef Anthrax lethal factor (7585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
作用メカニズム
証明書(CoA、COO、BSE/TSEと分析図)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
化学的性質と物理的性質
溶解度Solvent:DMSO, Max Conc. mg/mL: 2.3, Max Conc. mM: 5 with gentle warming
感度Moisture sensitive;light sensitive
分子量459.190 g/mol
XLogP3-2.500
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass458.993 Da
Monoisotopic Mass458.993 Da
Topological Polar Surface Area141.000 Ų
Heavy Atom Count25
Formal Charge0
Complexity614.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
ソリューション計算機
レビュー

顧客レビュー

Application Protocols

Manufacturer-tested applications and protocol parameters: Not specified for this item.

General recommendations for small-molecule use in research assays:

  • Stock preparation: Prepare fresh stocks in DMSO; filter if needed. Record exact concentration using mass and volumetric accuracy, or confirm by quantitative NMR/UV if applicable.
  • Working concentrations: Establish a broad range and refine using preliminary screens; include vehicle-only controls at matching solvent percentages.
  • Plate handling: Use low-binding, solvent-resistant plates/tubes. Pre-wet tips with solution to improve dosing precision at low volumes.
  • Light protection: Given the storage requirement “Protected from light,” use amber vials and minimize light exposure during setup.
  • Documentation: Record lot number, preparation date, storage conditions, and freeze–thaw cycles.

For method-specific parameters (e.g., WB, IF, IHC, FC, electrophysiology, enzyme assays), optimize empirically for your platform. Consult the SDS and CoA for any additional constraints.

Biological Roles

Item-specific biological function/target: Not specified for this item. No claims regarding mechanism, target class, or pathway are made here.

General context for small-molecule library members:

  • Such compounds are typically used as research tools to probe biochemical pathways, modulate protein function, or serve as starting points in hit discovery. Their biological roles are determined empirically through assays tailored to the suspected target class.
  • When identity and literature are known, typical information includes putative targets, binding modes, and selectivity profiles. For this item, consult the CoA and peer-reviewed sources tied to the CAS (569371-10-4) and CID (6604913) to confirm any reported roles before experimental use.

Best practices in biological evaluation:

  • Establish solubility and stability in assay media to avoid artifacts.
  • Run orthogonal assays (e.g., biochemical vs cellular) to differentiate direct target effects from pathway-level outcomes.
  • Implement selectivity panels early to identify off-target risks.
  • Monitor cytotoxicity in parallel when working with cellular systems, using appropriate viability assays.

Reminder: This product is for research use only and is not intended for diagnostic, therapeutic, or clinical applications.

Buffer Applications

This item is a small-molecule library compound, not a buffering agent. No intrinsic buffering system or pH range is specified for this product.

Practical guidance (when preparing assay buffers that include small-molecule stocks):

  • Prepare primary stocks in DMSO or a suitable organic solvent, then dilute into the desired biological buffer (e.g., PBS, HEPES, Tris) while maintaining final organic solvent ≤0.1–1% v/v as permitted by your assay.
  • Verify that the compound remains in solution across the working pH and ionic strength; precipitation can confound results.
  • Use filtering (0.22 μm) if compatible to remove particulates after dilution.

If your application requires a specific buffer system (HEPES pH 7.2–7.6; MOPS pH 6.5–7.9; Tris pH 7–9; general literature ranges), select the buffer based on your biological target, not this compound. No buffer recipes or pKa values are provided for UBP 301.

Green Alternatives

Greener chemistry considerations primarily concern solvents and handling rather than the compound itself, since this product is a specific small molecule and not interchangeable.

Solvent strategy (general):

  • Prefer greener solvents where feasible for dissolution and work-up: water > ethanol > isopropanol > ethyl acetate > acetone > acetonitrile > DMF > DMSO (considered acceptable in small volumes for screening).
  • Reduce DMSO volumes by using concentrated stocks and minimizing carryover in assays.

Comparison of common stock solvents (general characteristics):

  • Water: Greenest; limited by compound ionization/solubility.
  • Ethanol: Renewable, lower toxicity; miscible with water, good for moderately polar organics.
  • DMSO: Broad solvency, biologically tolerated at low %; higher energy cost to purify and disposal considerations.
  • DMF: Powerful polar aprotic solvent; more stringent EHS profile—avoid if DMSO suffices.

Operational measures:

  • Right-size aliquots to minimize freeze-thaw and waste.
  • Use amber vials and light-protective secondary containment to maintain stability (reduces wastage).
  • Implement microscale assays to reduce solvent and consumable usage.

Note: Since no structural data are provided, solvent choices must be validated empirically. Prioritize greener options first, escalating only as solubility demands.

Pharmaceutical Uses

No pharmacopeial grade or excipient role is specified for this item; it is supplied strictly for research use only.

General considerations (non-clinical, formulation science context):

  • Small-molecule research tools may be formulated into vehicles suitable for preclinical in vitro work (e.g., DMSO stocks diluted into aqueous buffers) or non-GLP exploratory in vivo studies when permitted by institutional approvals. For this item, no formulation guidance is provided.
  • Do not infer suitability for human or veterinary use. There is no USP/EP/JP monograph entry indicated, and no GMP status is claimed.

If formulation-like activities are performed in a research setting:

  • Validate solvent tolerability in the chosen biological system, control for vehicle effects, and characterize stability (LC-MS) in the vehicle across the dosing window.
  • Record exact lot, concentration, and vehicle composition for reproducibility.

Important: This product is not intended for therapeutic or diagnostic applications, and no clinical claims are made or implied.

Physical Properties

Item-specific values: Not specified for this item; refer to CoA/Spec Sheet for definitive data.

Typically reported properties for small-molecule library compounds (literature/general):

  • Appearance: Often supplied as a solid or film; some items may be oily or hygroscopic. Not specified for this item.
  • Melting point (MP): Not specified for this item.
  • Boiling point (BP): Not applicable/rarely reported for nonvolatile solids; not specified for this item.
  • Density: Not specified for this item.
  • Solubility: Not specified for this item. Many screening compounds dissolve in DMSO at 10–50 mM (general guidance), but empirical verification is required.
  • LogP/logD, pKa, and refractive index: Not specified for this item.

Practical characterization suggestions (general best practice):

  • Determine solubility by small-scale titration in DMSO, ethanol, or aqueous buffers across pH 2–9, monitoring by UV-Vis or HPLC.
  • If crystalline, DSC and TGA can inform thermal stability and potential solvates.
  • Record UV-Vis spectrum (200–400 nm) to estimate working wavelengths for analytical HPLC detection; do not assume a specific UV cutoff without data.

Important: Do not treat any of the above as specifications. For experimental planning, rely on the product’s CoA/SDS and your in-lab measurements.

Quality and Grades

Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.

How to interpret grades (general guidance):

  • Research grade: Suitable for R&D; purity and impurity profiles are defined on the CoA (e.g., HPLC area %). UV absorbance and trace metal limits may not be controlled unless stated.
  • Analytical/HPLC grade: Used primarily for solvents; implies low UV background and defined residue on evaporation. Not implied here unless specified.
  • Pharma/USP/EP grade: Conforms to pharmacopeial monographs. Not implied here.

Verification steps recommended for small-molecule library members:

  • Identity: HRMS and 1H/13C NMR.
  • Purity: Analytical HPLC/UPLC with at least two orthogonal methods (e.g., C18 gradient and HILIC if polar) and appropriate detection (UV at multiple wavelengths and/or MS).
  • Water content: Karl Fischer if hygroscopic or if aqueous solubility is critical. Not specified for this item.
  • Residual solvents and stabilizers: Not specified for this item; check CoA.

Batch documentation:

  • Request CoA with batch number, chromatograms, and spectral data. If UV cutoff, residual metals, or specific assay purity are critical to your application, confirm in writing prior to ordering.

Bottom line: Use the CoA as the single source of truth for this item’s grade, purity, and analytical acceptance criteria.

Reaction and Applications

This product is cataloged as a small-molecule/compound library member rather than a synthetic reagent. As such, it is not typically used to mediate or catalyze organic reactions.

Relevant applications (general for screening compounds):

  • In vitro biochemical assays: Evaluate compound activity against purified protein targets, enzymes, or receptors using spectroscopic or LC-MS readouts.
  • Cell-based phenotypic assays: Assess effects on cellular pathways or phenotypes. Optimize solvent carryover (often ≤0.1–0.5% DMSO) and include vehicle controls.
  • Electrophysiology/ion channel studies and binding assays may be applicable depending on the true identity; however, for this specific item no target is provided—consult literature and the CoA before designing target-focused assays.

Practical tips:

  • Establish a concentration-response curve spanning at least 8–10 points with duplicate/triplicate wells.
  • Confirm assay interference (fluorescence/absorbance quenching, redox activity, aggregation) using counter-screens (e.g., detergent sensitivity, light scattering, redox probes).
  • Verify chemical stability in assay buffer over the assay duration by LC-MS.

Important: Do not assume a pharmacological class or mechanism for this item in the absence of verified structural/target information. Use appropriate positive/negative controls relevant to your assay system.

Reaction Conditions

Not typically applicable. This product is provided as a research compound for screening/biological studies rather than as a reagent to run chemical reactions. No catalytic or stoichiometric reaction role is specified for this item.

General handling conditions relevant to solution preparation:

  • Dissolution: Begin with dry DMSO to prepare a concentrated stock (e.g., 10–50 mM if soluble). Warm gently (≤40°C) and sonicate as needed. Do not overheat or expose to bright light (store/handle in amberware).
  • Dilution: Add stock slowly into vigorously mixed buffer/media to minimize precipitation. Keep final organic cosolvent low as dictated by your assay.
  • Stability checks: Use quick LC-MS or analytical HPLC to assess stability over the intended usage period (e.g., 0, 2, 24 hours at room temperature or 37°C as relevant).

If you intend to use this material in a chemical transformation, first confirm the full structure and consult the literature for compatible conditions; none are provided here for UBP 301.

Safety and Handling

Item-specific hazard details: Not specified for this item; consult the Safety Data Sheet (SDS) for authoritative information.

From Product Data:

  • Storage: Store at 2–8°C, protected from light.
  • Shipping: Shipped on wet ice.

General laboratory precautions for research chemicals of unknown hazard class:

  • GHS/Signal word/H-statements/pictograms: Not specified for this item; refer to SDS.
  • PPE: At minimum, wear lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Work in a fume hood to avoid inhalation exposure.
  • Handling: Avoid dust/aerosol generation. Minimize skin/eye contact and ingestion. Use light-protection (amber vials/foil) during handling and storage as indicated.
  • Incompatibilities: Without structural data, avoid strong oxidizers, strong acids/bases, and reactive reducing agents until compatibility is known. Separate from food and feed.
  • First aid (general): If inhaled—move to fresh air; if on skin—wash with soap and water; if in eyes—rinse cautiously with water for several minutes; if ingested—rinse mouth and seek medical attention. Always follow the SDS for detailed measures.
  • Spill/accident: Contain solids with inert absorbent, avoid dust, and dispose of waste according to institutional and local regulations.

Note: Because specific hazards are not provided, adopt conservative handling practices and consult the product SDS before use.

Solvent Selection

Item-specific solubility and polarity: Not specified for this item; refer to CoA/Spec Sheet and perform a bench-top solubility screen.

General strategy for small-molecule library compounds:

  • Primary stock solvent: DMSO is typically preferred for biological screening due to broad solvating power and compatibility at ≤1% v/v in many assays.
  • Secondary options: DMF, ethanol, methanol for stocks; aqueous buffers (pH-adjusted) for immediate use if the compound bears ionizable groups.
  • Miscibility: DMSO mixes with water; pre-dilute DMSO stocks into media/buffer slowly with mixing to prevent precipitation.

Practical solubility screening (stepwise):

  1. Test solubility at 10 mM in dry DMSO. If insoluble, warm gently (≤40°C), sonicate, or decrease target concentration.
  2. If solubility remains poor, evaluate DMF or 1:1 DMSO:DMF, then alcoholic cosolvents (EtOH, MeOH).
  3. For aqueous use, assess pH dependence (e.g., buffers at pH 3, 7.4, 9) and include 0.1–1% DMSO as a cosolvent.
  4. Filter through 0.22 μm if compatible to remove particulates before assays.

Notes:

  • Avoid plastic adsorption for hydrophobic/charged compounds by using low-binding tubes and adding carrier proteins/detergents only if assay-compatible.
  • Do not assume stability in any solvent; confirm by LC-MS over your intended storage/use timeframe.
Storage and Reconstitution

From Product Data (item-specific):

  • Storage conditions: Store at 2–8°C, protected from light.
  • Shipping condition: Shipped on wet ice.

Reconstitution guidance (general, since no solvent/solubility is specified):

  • Solvent selection: Start with anhydrous DMSO to prepare a concentrated stock solution. If DMSO is unsuitable, test DMF or ethanol; for aqueous use, evaluate buffered solutions at relevant pH values.
  • Concentration: Common screening stocks are 10–50 mM (general practice); adjust based on actual solubility determined experimentally.
  • Technique: Allow vial to equilibrate to room temperature before opening to avoid condensation. Weigh quickly, minimize light exposure, and use amber vials.
  • Aliquoting: Divide into single-use aliquots to avoid repeated freeze–thaw cycles. Label with concentration, solvent, date, and lot number.
  • Short-term storage of solutions: Typically at 2–8°C for hours to days if stable; long-term at −20°C or −80°C may be appropriate for DMSO stocks—verify stability by LC-MS/HPLC. Because no stability data are provided for this item, perform your own verification.

Disposal: Follow institutional and local regulations for organic solvent waste and small-molecule research chemicals.

Note: Where specific values (solubility, stability windows) are critical, consult the CoA/Spec Sheet for this product and confirm empirically in your laboratory.

Structure and Identity

Brief overview: UBP 301 is listed as a small-molecule library member in Aladdin Scientific’s catalog. The supplier record does not include structural identifiers beyond CAS and CID.

Item-specific (from Product Data):

  • Product name: UBP 301 (SKU: U288472)
  • CAS: 569371-10-4
  • PubChem CID: 6604913
  • InChIKey: 160793 (as provided)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Category: Small Molecules & Compound Libraries (全部 / 可售 / 小分子和化合物库)

Structural features (general guidance):

  • Structural description cannot be provided without a formula or SMILES. If you require a detailed 2D/3D depiction, please consult the Certificate of Analysis (CoA), Spec Sheet, or validated databases using the CAS or CID.

Notes on identity control (general best practice):

  • Confirm identity via orthogonal methods prior to critical experiments: high-resolution MS, NMR (1H/13C), and HPLC/UPLC purity profiling.
  • Where an InChIKey/SMILES is missing or uncertain, use the CAS + CID to retrieve a vetted structure from a primary database (e.g., PubChem), and verify against the vendor CoA.
Synthetic Utility

UBP 301 is offered as a discrete small molecule rather than a synthetic building block or reagent. Without a disclosed structure, it is not possible to outline functional group compatibility or specific transformations.

General guidance for users considering derivatization (only after structure confirmation from CoA/literature):

  • If the compound contains common functional handles (e.g., amines, carboxylates, phenols, halides), classical transformations such as amide coupling, alkylation, Suzuki cross-coupling, or protection/deprotection may be feasible.
  • Prior to any derivatization, record baseline purity and identity, then re-characterize products via NMR, HRMS, and LC purity.

However, for this catalog item as listed:

  • No recommendation is made to use it as a reagent or starting material in synthesis.
  • No named reaction applicability is asserted, and no retrosynthetic value is claimed due to lack of structural disclosure in the provided data.

If synthetic utility is desired, retrieve the validated structure using the CAS or CID and consult the primary literature for established chemistry on this scaffold.

Target Specificity

Item-specific target, selectivity, and binding data: Not specified for this item.

Notes:

  • No protein target, receptor class, enzyme family, or pathway information is provided in the Product Data. Do not assume target engagement or selectivity without consulting the CoA and peer-reviewed literature associated with CAS 569371-10-4 and CID 6604913.
  • If your work requires defined selectivity, run an appropriate panel (e.g., enzymatic isoforms, receptor subtypes, off-target safety screens) using standard assay conditions and include orthogonal confirmation methods.

This section will remain blank of specifics until validated target information is supplied by the manufacturer or derived from reputable literature sources.

よくある質問

What is the purity of this product, and how is it determined?
This product is supplied at ≥98% purity, determined by HPLC. Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at 2–8 °C, protected from light. The material is light-sensitive — keep it in its original opaque or amber container.
How is this product shipped?
This product ships chilled on wet ice. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 569371-10-4, the molecular formula is C??H??IN?O?, and the molecular weight is 459.20 g/mol. InChIKey JHSYCOCOIYSZGI-NSHDSACASA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.